Urologie und Urogynäkologie Archives - Seite 2 von 3 - Laborie

Urologie und Urogynäkologie

LABORIE MEDICAL TECHNOLOGIES AND COGENTIX MEDICAL ANNOUNCE COMPLETION OF ACQUISITION OF COGENTIX MED

Urologie und Urogynäkologie

Completion of First Optilume® Procedure in Europe

Urologie und Urogynäkologie

Completion of First Optilume® Procedures in the National Health Service (NHS), UK

Urologie und Urogynäkologie

Laborie Medical Technologies Acquires Exclusive License to Optilume®

TGA Optilume V3

Urologie und Urogynäkologie

Laborie’s Optilume® Urethral Drug Coated Balloon Technology Wins Approval from Australia TGA

Urologie und Urogynäkologie

Laborie Medical Technologies erwirbt Pelvalon

Urologie und Urogynäkologie

Laborie’s Optilume® Issued Category 1 CPT Code by American Medical Association

Unkategorisiert |

Urologie und Urogynäkologie

Laborie Medical Technologies Announces Agreement to Acquire Urotronic for up to $600 Million

Acquisition expands urology portfolio and demonstrates Laborie’s commitment to providing proven, innovative solutions to physicians and patients globally

Unkategorisiert |

Urologie und Urogynäkologie

Laborie Medical Technologies Acquires Urotronic

Urotronic joins Laborie as part of a long-term growth strategy for the Portsmouth-based medical device company. Urotronic’s Optilume® BPH Catheter System, a unique minimally invasive surgical therapy (MIST), is a paradigm shift for patients and clinicians in global interventional urology.

Urologie und Urogynäkologie

Laborie Medical Technologies Invests in iO Urology and the CarePath Uroflow Device

Laborie Medical Technologies  announced a strategic equity investment in Bright Uro, an early-stage medical technology company headquartered in Irvine, CA.

Seite 2 von 3«123 »